|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
7 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| General and administrative expenses | |||||
| Net revenue | |||||
| Net patient revenue | |||||
| Other revenue | |||||
| Total net revenue | |||||
| Cost of services: | |||||
| Salaries and related costs | |||||
| Rent, clinic supplies, contract labor and other | |||||
| Provision for doubtful accounts | |||||
| Total cost of services | |||||
| Selling, general and administrative expenses | |||||
| Long-lived asset impairment charges | |||||
| Operating income (loss) | |||||
| Change in fair value of 2L Notes | |||||
| Change in fair value of warrant liability | |||||
| Interest expense on redeemable preferred stock | |||||
| Change in fair value of contingent common shares liability | |||||
| Change in fair value of warrant liability and contingent common shares liability | |||||
| Interest expense, net | |||||
| Other expense, net | |||||
| Loss before taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Net income attributable to non-controlling interests | |||||
| Net loss attributable to ATI Physical Therapy, Inc. | |||||
| Less: Series A Senior Preferred Stock redemption value adjustments | |||||
| Less: Series A Senior Preferred Stock cumulative dividend | |||||
| Net loss available to common stockholders, diluted | |||||
| Net loss available to common stockholders, basic | |||||
| Loss per share of Class A common stock: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...